Product Description
Brand Boditech
Sample Type Serum/ Plasma
SMFP-74 24T
CAT No SMFP-76
Biomarker Therapeutic Drug Monitoring
Therapeutic Drug Monitoring (TDM) is to optimize biologic treatment for an individual patient. AFIAS Total Anti-Infliximab can detect the presence of anti-drug antibodies against Infliximab, requiring only a small amount of human serum or plasma, and delivering results in 22 minutes. This allows physicians to verify the presence of anti-drug antibodies immediately before the next administration.
Rapid and Reliable TestingGain results in under 15 minutes with Boditech AFIAS Total Anti-Infliximab, which combines high sensitivity (1.0 AU/mL) and specificity in a compact, disposable cartridge format. The integrated pre-calibration and barcode features make workflow effortless and minimize error potential, supporting efficiency in busy clinical environments.
Easy Integration and UsageCompatible exclusively with the AFIAS Analyzer Series, this immunofluorescence cartridge requires no additional calibration. Simply load human serum samples into the cartridge, insert into the analyzer, and receive accurate, real-time results automatically. Lightweight and portable, it suits any clinical diagnostics setting.
Safe, Traceable, and EfficientEach kit includes 25 single-use cartridges, ensuring hygienic operation and traceable lot information for quality assurance. All components are made from medical-grade plastic and reagents, and are supplied with clear storage instructions (2-8C) for optimum preservation and reliability throughout the 12-month shelf life.
FAQ's of Boditech AFIAS Total Anti-Infliximab:
Q: How is the Boditech AFIAS Total Anti-Infliximab test performed?
A: To perform the test, human serum is loaded into the disposable immunofluorescence cartridge, which is then inserted into any compatible AFIAS Analyzer Series device. The analyzer automatically processes the sample, with results available within 15 minutes.
Q: What does the AFIAS Total Anti-Infliximab kit measure?
A: This kit quantitatively detects total anti-infliximab antibodies in human serum samples, aiding in therapeutic drug monitoring for patients undergoing infliximab therapy.
Q: When should the test be used in clinical practice?
A: It is ideal for routine or on-demand monitoring of patients receiving infliximab. Use the kit whenever there is a clinical need to assess anti-infliximab antibody levels to optimize treatment efficacy.
Q: Where can the kit be utilized?
A: The kit is suitable for use in clinical laboratories, diagnostic centers, and hospital settings across India, provided an AFIAS Analyzer Series device is available.
Q: What is the benefit of a pre-calibrated cartridge and integrated barcode?
A: Pre-calibration eliminates the need for manual calibration, reducing setup complexity, while the integrated barcode ensures accurate lot tracking and data management for enhanced operational safety.
Q: How should the cartridges be stored for maximum shelf life?
A: Store all cartridges at 2-8C (refrigerated). Proper storage as per instructions helps maintain product efficacy for up to 12 months from the manufacturing date.
Q: Why choose this kit for therapeutic drug monitoring?
A: The kit provides rapid, accurate, and highly sensitive results with minimal operator input, supporting clinical decisions for infliximab therapy management. Its disposable, portable design and reliable performance make it a practical choice for modern healthcare teams.